Prime
Treatments
Testing and Advancements Index
The Prime Treatments, Testing and Advancements Index is designed to track both event-driven news and long-term trends of companies engaged in developing treatments and vaccines, or diagnostic technology, in the fight against infectious diseases.
FACT SHEET
Prime Treatments, Testing and Advancements Primer
PDF
Infectious Diseases: Prime Treatments, Testing and Advancements Overview
PDF
Prime Treatments, Testing and Advancements Index Methodology Guide
PDF
Prime Treatments, Testing and Advancements Factsheet
PDF
Prime Treatments, Testing and Advancements Index
VIDEO
INDEX KEY FACTS
Base Date: December 12, 2019
Total number of holdings:
50
Launch date: June 08, 2020
Reconstitution: Quarterly (March, June, September and December)
Index calculation agent: Solactive AG
Weighting scheme: Modified Market Capitalization
INDEX SYMBOLS
| Version | Bloomberg | Reuters | ISIN |
|---|---|---|---|
| Prime Treatments, Testing and Advancements Index GTR | PGERM | .PGERMG | DE000SL0A030 |
| Prime Treatments, Testing and Advancements Index NTR | N/A | .PGERMN | DE000SL0A022 |
| Prime Treatments, Testing and Advancements Index PR | N/A | .PGERMP | DE000SL0A014 |
INDEX COMPOSITION
| Component Name | Ticker | Weight |
|---|---|---|
| BIONTECH SE | BNTX | 7.92% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | 6.69% |
| QUEST DIAGNOSTICS INC | DGX | 5.78% |
| LABCORP HOLDINGS INC | LH | 5.71% |
| ZAI LAB LTD | ZLAB | 5.19% |
| MODERNA INC | MRNA | 4.67% |
| NOVAVAX INC | NVAX | 4.35% |
| BIO-RAD LABORATORIES INC | BIO | 4.03% |
| VAXCYTE INC | PCVX | 4.01% |
| QUIDELORTHO CORPORATION | QDEL | 3.79% |
| IMMUNITYBIO INC | IBRX | 3.77% |
| DYNAVAX TECHNOLOGIES CORP | DVAX | 3.60% |
| IMMUNOCORE HOLDINGS PLC | IMCR | 3.58% |
| BIOCRYST PHARMACEUTICALS INC | BCRX | 3.52% |
| OPKO HEALTH INC | OPK | 2.74% |
| VIR BIOTECHNOLOGY INC | VIR | 2.68% |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | 1.94% |
| ARBUTUS BIOPHARMA CORP | ABUS | 1.91% |
| CUREVAC BV | CVAC | 1.72% |
| FULGENT GENETICS INC | FLGT | 1.62% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | 1.49% |
| CORMEDIX INC | CRMD | 1.45% |
| SIGA TECHNOLOGIES INC | SIGA | 1.26% |
| EMERGENT BIOSOLUTIONS INC | EBS | 1.20% |
| GILEAD SCIENCES INC | GILD | 0.90% |
| PFIZER INC | PFE | 0.86% |
| ABBOTT LABORATORIES | ABT | 0.86% |
| ABBVIE INC | ABBV | 0.84% |
| ELI LILLY & CO | LLY | 0.84% |
| JOHNSON & JOHNSON | JNJ | 0.82% |
| TAKEDA PHARM-ADR | TAK | 0.80% |
| ORASURE TECHNOLOGIES INC | OSUR | 0.80% |
| SANOFI-ADR | SNY | 0.79% |
| ASTRAZENECA PLC-SPONS ADR | AZN | 0.78% |
| MERCK & CO. INC. | MRK | 0.77% |
| GSK PLC-SPON ADR | GSK | 0.76% |
| ATEA PHARMACEUTICALS INC | AVIR | 0.75% |
| OCUGEN INC | OCGN | 0.73% |
| REGENERON PHARMACEUTICALS | REGN | 0.73% |
| ENANTA PHARMACEUTICALS INC | ENTA | 0.60% |
| XBIOTECH INC | XBIT | 0.57% |
| VAXART INC | VXRT | 0.48% |
| INOVIO PHARMACEUTICALS INC | INO | 0.38% |
| INVIVYD INC | IVVD | 0.29% |
| HILLEVAX INC | HLVX | 0.23% |
| INFLARX NV | IFRX | 0.23% |
| CHIMERIX INC | CMRX | 0.21% |
| CEL-SCI CORP | CVM | 0.17% |
| RENOVARO BIOSCIENCES INC | RENB | 0.17% |
| GRITSTONE BIO INC | GRTS | 0.02% |